Becky Slack, M.S.
Senior Statistical Analyst
Degree
- M.S. in Biometry, Cornell University, Ithaca, NY
Publications
2012
You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, Nguyen S, Skibber JM. 2012. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum 55(12): 1213-9.
Pishviain M, Slack R, Koh E, Beumer J, Hartley M, Cotarla I, Deeken J, He A, Hwang J, Malik S, Strychor S, Egorin M, Marshall J. 2012. A phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. Cancer Chemother Pharmacol 70:843-53.
Li Y, Baker JJ, Korostyshevskiy VR, Slack RS, Plankey MW. 2012. The association of intimate partner violence, recreational drug use with HIV seroprevalence among MSM. AIDS Behavior 16(3): 491-8.
2011
Isaacs C, Herbolsheimer P, Liu MC, Wilkinson M, Ottaviano Y, Chung GG, Warren R, Eng-Wong J, Cohen P, Smith KL, Creswell K, Novielli A, Slack R. 2011. Phase I/II study of sorafenib with anastrozole to overcome resistance to aromatase inhibitors in patients with hormone receptor positive (ER/PR+) aromatase inhibitor resistant metastatic breast cancer. Breast Cancer Research and Treatment 125(1): 137-143.
2010
Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Hwang J, Slack RS, Noone A-M, Harter KW. 2010. Fractionated stereotactic radiosurgery for reirradiation of head and neck cancer. International Journal of Radiation Oncology, Biology, and Physics 77(6): 1411-1419.
Oermann E, Slack R, Hanscom H, Lei S, Suy S, Park H, Kim J, Sherer B, Collins B, Satinsky A, Harter KW, Patipps G, Constantinope N, Dejter S, Maxted W, Regan J, Pahira J, McGeach K, Jha R, Dawson N, Dritschilo A, Lynch J, Collins S. 2010. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Technology in Cancer Research and Treatment 9(5): 453-461.
2009
Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. 2009. Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis. Journal of Clinical Oncology 27(17): 2831-7.
Shah R, Selby ST, Yokley B, Slack RS, Hurley CK, Posch P. 2009. TNF, LTA and TGFB1 genotype distributions among acute graft-versus-host disease (AGVHD) subsets after HLA-matched unrelated hematopoietic stem cell transplantation: A pilot study. Tissue Antigens 74(1): 50-6.
Baker J, Plankey M, Josayma Y,Elion R, Chiliade P, Shahkolahi A, Menna M, Miniter K, Slack R, Yang Y, Masterman B, Margolick JB. 2009. The prevalence of rectal, urethral, and pharyngeal Neisseria gonorrheae and Chlamydia trachomatis among asymptomatic men who have sex with men in a prospective cohort in Washington, D.C. AIDS Patient Care and STDs 23(8): 1-4.
Sun JF, Wu RR, Norris C, Noone A-M, Amankwa-Sakyi M, Slack R, Marshall JL. 2009. Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers. Gastrointestinal Cancer Research 3(4): 134-40.
Wu RR, Lindenberg PA, Slack R, Noone A-M, Marshall JL, He AR. 2009. Evaluation of hypertension as a marker of bevacizumab efficacy. Journal of Gastrointestinal Cancer 40(3-4): 101-8
2008
Deeken J, Slack R, Marshall J. 2008. Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: To test or not to est, that is the question. Cancer 133(7): 1502-10.
2007
White AM, Banovac F, Yousefi S, Slack RS, Spies JB. 2007. Uterine fibroid embolization: The utility of aortography in detecting ovarian artery collateral supply. Radiology 244(1): 291-8.
2006
Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM. 2006. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Experimental Cell Research 312(8): 1240-53.
Lazaro AM, Steiner NK, Cao K, Slack R, Chen DS, Xiao Y, Beduhn E, Ng J, Hartzman RJ, Hurley CK. 2006. Searching for HLA-DRB1*1206 in volunteer marrow donors in four US population groups. Tissue Antigens 68: 439-41.
2005
Marshall JL, Gulley JL, Arlen P, Beetham PK, Tsang K-Y, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J. 2005. Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinica-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. Journal of Clinical Oncology 23(4): 1-12.
Chepko G, Slack R, Carbott D, Kahn S, Stedman L, Dickson RB. 2005. Cell type population sizes and cell cycle activity are differentially altered in ducts and lobules of TGFα and c-Myc transgenic mouse mammary epithelium. Tissue and Cell 37: 393-412.
Isaacs C, Slack RS, Gehan EA, Ballen K, Boccia R, Areman E, Hayes DF, Herscowitz H, Lippman M. 2005. A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients. Breast Cancer Research and Treatment 93: 125-34.
Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnel C, Ullmer L, Gallagher A, Cullen J, Gehan EA, Hayes DF, Isaacs C. 2005. Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. Journal of Clinical Oncology 23(28): 6919-30.
2004
Pack SD, Alper OM, Stromberg K, Augustus M, Ozdemirli M, Miermont AM, Klus G, Rusin M, Slack R, Gacker NF, Ried T, Szallasi Z, Alper O. 2004. Simultaneous suppression of EGFR and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line. Cancer Research 64(3): 789-94.
2003
Stearns V, Singh B, Tsangaris T, Crawford J, Novielli A, Ellis MJ, Isaacs C, Pennanen M, Tibery C, Farhad A, Slack R, Hayes DF. 2003. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clinical Cancer Research 9: 124-33.
Baldassarre LA, Steiner NK, Jones P, Tang T, Slack R, Ng J, Hartzman RJ, Hurley CK. 2003. Limited diversity of HLA-DRB1*02 Alleles and DRB1-DRB5 haplotype associations in four United States populations groups. Tissue Antigens 61: 249-52.
Rizzuto G, Li L, Steiner N, Slack R, Tang T, Heine U, Lin Y, Ng J, Hartzman RJ, Hurley CK. 2003. Diversity within the DRB1*08 allele family in four populations from a United States hematopoietic stem cell donor database and characterization of five novel DRB1*08 alleles. Human Immunology 64: 607-13.
Han Z, Slack RS, Li W, Papadopoulos V. 2003. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. Journal of Receptors and Signal Transduction Research 23(2-3): 225-38.
2002
Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. 2002. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of Surgical Oncology 9(3): 235-42.
Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport VG, Morris EK, Laver JH, Reaman GH, Cairo MS. 2002. Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilm’s tumor: A Children’s Cancer Group (CCG) report. Annals of Oncology 13: 460-9.
Meehan K, Slack R, Gehan E, Herscowitz H, Areman E, Ebadi M, Cairo M, Lippman M. 2002. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients. Journal of Hematotherapy and Stem Cell Research 11(2): 415-21.
Gans CP, Tang TF, Slack R, Ng J, Hartzman RJ, Hurley CK. 2002. DRB1*14 diversity and DRB3 associations in four major population groups in the United States. Tissue Antigens 59(5): 364-9.
Chen DS, Tang TF, Pulyaeva H, Slack R, Tu B, Wagage D, Noreen H, Perlee L, Ng J, Hartzman RJ, Hurley CK. 2002. Relative HLA-DRB1*04 allele frequencies in the five major populations in the United States and six new DRB1*04 alleles. Human Immunology 63(8): 665-72.
2001
Houtenbous I, Bracho F, Davenport V, Slack R, Van de Ven C, Suen Y, Killen R, Shen V, Sender L, Cairo M. 2001. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of auto graft vs leukemia effect and post transplant immuno and chemotherapy. Bone Marrow Transplantation 27(2): 145-53.
Meehan KR, Wu A, Hassan R, Miao Y, Chawla J, Slack R, Gehan E, Herscowitz HB. 2001. Ex vivo cytokine activation of peripheral blood stem cells: A potential role for adoptive cellular immunotherapy. Journal of Hematotherapy & Stem Cell Research 10: 283-90.
Goldman SC, Bracho F, Davenport V, Slack R, Areman E, Shen V, Lenarsky C, Weinthal J, Hughes R, Cairo MS. 2001. A feasibility study of interleukin-11 and G-CSF following myelosuppressive chemotherapy to mobilize peripheral blood stem cells (DC34+) from heavily pretreated patients. American Journal of Pediatric Hematologic Oncology 23(5): 300-5.
Yang X, Wei L, Tang C, Slack R, Mueller M, Lippman M. 2001. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Research 16(13): 5284-8.
2000
Collins M, Tang T, Slack R, Sintasath D, Hartzmann RJ, Ng J, Hurley CK. 2000. The relative frequencies of HLA-DRB1*01 alleles in the major U.S. populations. Tissue Antigens 55: 48-52.
Ellis J, Henson V, Slack R, Ng J, Hartzman RJ, Hurley CK. 2000. The frequencies of HLA-A2 alleles in five U.S. population groups: Predominance of A*02011 and identification of HLA-A*0231. Human Immunology 61: 334-40.
Kosman C, Steiner N, Pulyaeva H, Mitton W, Slack R, Hartzman RJ, Ng J, Hurley CK. 2000. The relationship between HLA-B45 and B*5002 in the five major U.S. population groups. Tissue Antigens 55: 437-42.
Pimtanothai N, Rizzuto GA, Slack R, Steiner NK, Kosman CA, Jones PF, Koester R, Ng J, Hartzman R, Hurley CK. 2000. The diversity of alleles encoding HLA-B40: The relative frequencies in U.S. populations and description of five novel alleles. Human Immunology 61(8): 808-15.
Tang T, Huang A, Pappas A, Slack R, Ng J, Hartzman RJ, Hurley C. 2000. Relative frequencies of DRB1*11 alleles and their DRB3 associations in five major population groups in the United States. Human Immunology 61(8): 820-7.
1999
Arun B, Slack R, Gehan E, Spitzer T, Meehan K. 1999. Survival after autologous hematopoetic stem cell transplantation for patients with inflammatory breast cancer. Cancer 85(1): 93-9.
Hsu E, Bei M, Slack R, Hartzman R, Ng J, Hurley C. 1999. HLA-A*28 allele frequencies in the five major U.S. ethnic groups. Human Immunology 60: 159-67.
Wu A, Michejda M, Mazumder A, Meehan K, Menendez F, Tchabo J-G, Slack R, Johnson M, Bellanti J. 1999. Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood and cord blood. Pediatric Research, 46(2): 163-9.
Bei M, Ng J, Slack R, Ellis J, Hartzman RJ, Hurley CK. 1999. The relative frequencies of HLA-A*10 alleles in five major U.S. ethnic populations. Tissue Antigens 54: 295-9.
Sintasath, DM, Tang T, Slack R, Tilley EE, Ng J, Hartzman RJ, Hurley CK. 1999. Relative HLA DRB1*13 allele frequencies and DRB3 associations of unrelated individuals from five U.S. populations. Human Immunology 60: 1001-10.
Burnett C, Steakley C, Slack R, Roth J, Lerman C. 1999. Patterns of breast cancer screening among lesbians at increased risk for breast cancer. Women and Health 29: 35-55.
Hanfelt J, Slack R, Gehan E. 1999. A modified version of Simon’s optimal design where the criterion is the median sample size. Controlled Clinical Trials 20: 555-66.
Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M. 2000. KAI1 protein is down-regulated during the progression of human breast cancer. Clinical Cancer Research 6(9): 3424-9.
Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi O, Gelmann EP. 2000. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Research 60(21): 6111-5.
Updated January 15, 2013